PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-gamma coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-alpha. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is elevated in liver in mouse models of diabetes and regulates the expression of TRB3, an inhibitor of insulin-dependent AKT activation [87, 88].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [88]
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“jpg" NDATA ITEM> ]> Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscl”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“Despite its importance in promoting mitochondrial function in skeletal muscl”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · cited 1×
“Overexpression of PPAR-α and its heterodimeric partner RX”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“Free fatty acids are thought to inhibit glucose us”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“Both TRB-3 mRNA and PGC-1 mRNA were elevated in LIRKO mice, which have a knockout of the insulin receptor in live”
BackgroundSelf-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“In the fed state, insulin inhibits hepatic glucose output through a cascade of phospholipid-dependent kinases that activate Akt/PKB by phosphorylating it at Thr308 and Ser473 (refs”
Background
Cited by
Items 501–552 of 552
Ige, A. O., Fatokun, B. P., Emediong, I. E., Odetola, A. O., Adele, B. O., & Adewoye, E. O. (2020) · Nigerian Journal of Physiological Sciences · Cited by 1
Toward a Mechanistic Understanding of Hepatic Insulin Action and Resistance
Cook, J. R. (2014) · doi:10.7916/d8j38r4z · Cited by 1
Ong, K. T. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 2
Fatty Acid and Glucose Metabolism in Cardiac Disease
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50016-4 · Cited by 1
Development and use of tools to study metabolic consequences of altered polyamine catabolism
Cerrada‐Gimenez, M. (2010) · UEF eRepo (University of Eastern Finland) · Cited by 1
Tribbles 3 blunts exercise-induced skeletal muscle adaptationPreprint
Choi, R. H., McConahay, A., Johnson, M. B., Ojemuyiwa, M., Phillips, B. J., Jeong, H.-W., & Koh, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.16.665065 · Cited by 1
Watve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_12
Røst, T. H. (2008) · NVA (Nasjonalt vitenarkiv)
Chapter 10 Forkhead proteins and the regulation of hepatic gene expression
Barthel, A., Herzig, S., & Schmoll, D. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05010-1
Self-citationThe regulation of metabolic gene expression in humans
Tisdale, P. B. (2011) · Nottingham ePrints (University of Nottingham) · Cited by 1
Adipose tissue inflammation, liver fat and insulin resistance in humans
Makkonen, J. (2010) · Työväentutkimus Vuosikirja
Pihlajamäki, J., & Patti, M. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05012-5 · Cited by 2
Insulin sensitivity of hepatic glucose and lipid metabolism in animal models of hepatic steatosis
Grefhorst, A. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Genomic and Epigenomic Studies of Acute Myeloid Leukemia with CEBPA Abnormalities
Wouters, B. J. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Signaling in Diabetes and Metabolic Syndrome
Marín-García, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9461-5_16
Cre-mediated conditional gene targeting to understand liver functions
METZGER, D., & Chambon, P. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.11.021
Drug discovery using the regulation of gene expression
St‐Pierre, Y. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.7.987
Protective Effect of PGC-1 on Lipid Overload-induced Apoptosis in Vascular Endothelial Cell
Koh, E. H., Kim, Y. M., Kim, H., Lee, W. J., Won, J. C., Kim, M., Lee, K., & Park, J. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.3.151
Enhanced methylglyoxal formation in cystathionine γ-lyase knockout mice
Untereiner, A. A. (2011) · University Library - University of Saskatchewan (University of Saskatchewan)
Mosselman, S., Strauss, J. F., Wood, J. R., Nelson-DeGrave, V. L., Jansen, E., McAllister, J. M., Goodarzi, M. O., Jones, M. R., Chen, Y. I., Azziz, R., et al. (2015)
Metabolic Syndrome, Diabetes and Cardiometabolic Risks in Aging
Marín-García, J., Goldenthal, M. J., & Moe, G. W. P. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74072-0_9
The Drosophila PGC-1 homologue Spargel coordinates mitochondrial biogenesis to insulin-signalling
Tiefenböck, S. K. (2009) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005831335
The role of ER stress in lipogenesis and insulin resistance in response to over nutrition
Sun, R. (2016) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27581124
Greene, N. P. (2011) · OakTrust (Texas A&M University Libraries)
CONTROL TRANSCRIPCIONAL I AL·LOSTÈRIC DEL GEN CARNITINA PALMITOÏLTRANSFERASA 1B (CPT1B)
de Farmàcia, F., de Bioquímica, D., & Molecular, I. B. (2006)
walia, R., & walia, R. (2011) · Protocol Exchange · doi:10.1038/protex.2011.226
Jiang, J., & Cheng, J. (2016) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000193
“[31] demonstrated that a sharp, adenoviral-mediated reduction of hepatic PGC-1α increased insulin sensitivity in vivo.”
BackgroundTranscriptional Regulation of Mitochondrial Biogenesis and Quality Control
Suliman, H. B., & Piantadosi, C. A. (2015) · Oxidative stress and disease · doi:10.1201/b19420-6
Glucocorticoids as Modulators of Adipose Inflammation
Morton, N. M. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch8
Crosstalk between Insulin and Wnt Signaling Pathways
Sun, J. (2010) · TSpace (University of Toronto) · Cited by 1
Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
Akie, T. E. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2388v
“While mice heterozygous for PGC-1α had increased liver triglyceride, cholesterol, and insulin resistance (Estall et al., 2009), another model revealed improved insulin sensitivity with PGC-1α knockdown (Koo et al., 2004).”
BackgroundThe Role of Transcription Factor 7-Like 2 in Hepatic Glucose Metabolism
Ip, W. (2014) · TSpace (University of Toronto)
Botteri, G. (2018) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Dechandt, C. R. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-13092018-104230
Hypoglycemic episodes exacerbate skeletal muscle insulin resistance in type 2 diabetes mellitus
Zufry, H., Rosdiana, R., Sucipto, K. W., Ekadamayanti, A. S., & Firdausa, S. (2025) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_388_24
“[21] This activation subsequently activates Akt, inducing the phosphorylation of AS160, which facilitates the translocation of GLUT4 to the cell membrane, thereby enabling glucose uptake into muscle cells.”
Bressan, C. A. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Hannou, S. A. (2014) · theses.fr (ABES) · doi:10.70675/aeb857aez253cz4b9azab90zc22738177adc · Cited by 1
Role of PGC-1β and TIF2 co-regulators in mouse skeletal muscle function
Ramamoorthy, T. G. (2013) · theses.fr (ABES) · doi:10.70675/e05002c4z4806z4363z90b1z0e406b6c0e4c
Contrôle de la masse fonctionnelle des cellules β pancréatiques par les glucocorticoïdes et pgc-1α
Besseiche, A. (2015) · theses.fr (ABES) · doi:10.70675/f16ecd6fza687z4a5fzac34zc26774dc9c3f
Implication de la pseudokinase dans la réponse aux inhibiteurs de mTor
Vicier, C. (2017) · theses.fr (ABES) · doi:10.70675/6745890az9d85z41f7z9f95z726d5a52b917
Stefanovska, B. (2019) · theses.fr (ABES) · doi:10.70675/31fe0043zbb1az45d6z84e3ze78ee83670a0
Carper, D. A. (2020) · theses.fr (ABES) · doi:10.70675/75973fe1z43fbz422cz9d70zf7b3b5b7e15f
Gao, R., Zhang, Y., & Quan, L. (2026) · Comprehensive physiology · doi:10.1002/cph4.70248 · Cited by 1
Nardi, F. (2015) · Discovery Research Portal (University of Dundee)
The role of PPARalpha and growth hormone in hepatic lipid metaboism and atherosclerosis
Ljungberg, A. (2006) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Metadata
- Authors
- Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Montminy, Marc
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 530-534
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1603786143
- Cited by
- 550
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 13 · 2018: 22 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 34 · 2013: 31 · 2012: 31
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM037828, GM R01 37828)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1, insulin resistance, PPARα, type 2 diabetes, hepatic insulin sensitivity, glucose tolerance, Akt signaling, fasting hypoglycemia, nuclear receptors, hepatic gluconeogenesis, RNAi knockdown
- MeSH terms
- Animals, Base Sequence, Diabetes Mellitus, Type 2, DNA, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Signal Transduction, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Cell Cycle Proteins, RNA Interference, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.